Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MME | P08473 | 4/20 | 0.40 |
| ▸ | GNPAT | O15228 | 1/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.38 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL18528187 | 1.00 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2MME | |
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL2220 | 1.00 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2MME | |
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL19741548 | 1.00 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2MME | |
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL167682 | 1.00 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2MME | |
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL11297426 | 0.97 | CA2 (0.44) | CA2CA4TDP1SMN1; SMN2MME | |
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL6954583 | 0.97 | CA2 (0.44) | CA2CA4TDP1SMN1; SMN2MME | |
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL27949540 | 0.97 | CA2 (0.44) | CA2CA4TDP1SMN1; SMN2MME | |
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL10763594 | 0.97 | CA2 (0.44) | CA2CA4TDP1SMN1; SMN2MME | |
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL28052876 | 0.95 | CA2 (0.42) | CA2CA4TDP1SMN1; SMN2MME | |
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL431199 | 0.91 | GLRA1 (0.43) | CA2CA4TDP1SMN1; SMN2MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2808 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746912-A1 | ORGANIC CYTOTOXIN OLIGOMERS AND USES THEREOF AS A PAYLOAD IN ANTIBODY-DRUG CONJUGATES | Simris Biologics GmbH (DE) | 2026-05-27 | — | — | EP | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4727654-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4727655-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4720086-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Zealand Pharma A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| EP-4720087-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Zealand Pharma A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| EP-3570864-B1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4218790-B1 | MODULATORS OF COMPLEMENT ACTIVITY | UCB HOLDINGS INC (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4663654-A1 | POLYPEPTIDE AND DERIVATIVE THEREOF, COMPOSITION, AND USE THEREOF | Hangzhou Sciwind Biosciences Co., Ltd. (CN) | 2025-12-17 | — | — | EP | claimed |
| US-20250222146-A1 | Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof | RAYZEBIO, INC. (US) | 2025-07-10 | — | — | US | claimed |
| WO-2005073164-A1 | THERAPEUTIC AND CARRIER MOLECULES | PEPLIN BIOLIPIDS PTY LTD (AU) | 2005-08-11 | — | — | WO | claimed |
| US-20040248911-A1 | 7H-pyrrolo[2,3-d]pyrimidine derivatives | BOLD GUIDO (CH) | 2004-12-09 | — | — | US | claimed |
| US-20020155962-A1 | Nonaqueous hair styling composition and method of use | ANDREW JERGENS COMPANY, THE | 2002-10-24 | — | — | US | claimed |
| EP-0711156-A4 | USE OF N-METHYL-ASPARTIC ACID FOR ENHANCING GROWTH AND ALTERING BODY COMPOSITION | UNIV MARYLAND (US) | 1998-03-04 | — | — | EP | claimed |
| US-5691377-A | ACTIVATE GROWTH HORMONE SECRETION | UNIVERSITY OF MARYLAND EASTERN SHORE AND UNIVERSITY OF MARYLAND COLLEGE PARK (US) | 1997-11-25 | — | — | US | claimed |
| EP-0711156-A1 | USE OF N-METHYL-ASPARTIC ACID FOR ENHANCING GROWTH AND ALTERING BODY COMPOSITION | UNIVERSITY OF MARYLAND AT COLLEGE PARK AND UNIVERSITY OF MARYLAND EASTERN SHORE (US) | 1996-05-15 | — | — | EP | claimed |
| WO-1995003793-A1 | USE OF N-METHYL-ASPARTIC ACID FOR ENHANCING GROWTH AND ALTERING BODY COMPOSITION | UNIVERSITY OF MARYLAND AT COLLEGE PARK AND UNIVERSITY OF MARYLAND EASTERN SHORE (US) | 1995-02-09 | — | — | WO | claimed |
| EP-0324595-B1 | Amino-functional compounds as builders/dispersants in detergent compositions | PROCTER & GAMBLE (US) | 1995-01-11 | — | — | EP | claimed |
| US-5221711-A | Reacting maleic anhydride with alcohols to form halt-esters, reacting product with certain amines | THE PROCTER & GAMBLE COMPANY (US) | 1993-06-22 | — | — | US | claimed |
| EP-0324595-A2 | Amino-functional compounds as builders/dispersants in detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1989-07-19 | — | — | EP | claimed |